December 15, 2016 / 11:31 PM / a year ago

BRIEF-Aceto Corp comments on recent announcements impacting generic pharmaceuticals industry

Dec 15 (Reuters) - Aceto Corp

* Commented today on recent announcements impacting generic pharmaceuticals industry

* Co has no reason to believe it is involved in reported matters or that any of its products are among products covered in these proceedings

* Remains confident in pending acquisition of products from Citron, looks forward to consummating transaction later this month or in early 2017

* State of Connecticut announced it and nineteen other states have filed a civil complaint against six generic drug manufacturers or suppliers

* Aceto is not acquiring Citron entity that is subject of DOJ investigation or civil complaint Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below